Top compounds associated with response to VCP


Feature Type Standardized
Nominal ANOVA
mRNA SZ4TA2 CTRPv2 pan-cancer AAC 0.15 0.007
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.086 0.007
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.099 0.007
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.01
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC 0.08 0.01
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.083 0.01
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.076 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA azacitidine CTRPv2 pan-cancer AAC -0.093 0.01
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.094 0.02
Download CSV